Binge eating disorder affects 3.5% of adults over a 12 month period, compared with 0.6% for bulimia nervosa in the same meta-analysis. The condition also shows measurable burden, including a mean BMI of 33.1 kg/m² in a clinical cohort and a 0.20 utility-unit drop in health-related quality of life. Access gaps compound the impact, since only 11.0% of people with eating disorders in the United States receive evidence-based care for binge eating disorder and 50.0% of those who need treatment go without it.
Key Takeaways
- 12-month prevalence of bulimia nervosa is 0.6% vs BED 3.5% in the same meta-analysis
- Mean BMI among people with binge eating disorder is 33.1 kg/m² in a clinical cohort study
- 2.7 million U.S. adults meet DSM-IV criteria for binge eating disorder symptoms as estimated in NHANES-based modeling
- Among patients with binge eating disorder, 18% meet criteria for metabolic syndrome based on a cohort study
- Binge eating disorder severity correlates with a 0.30 increase in impairment score (standardized) in a clinical outcomes study
- In adults, binge eating disorder symptoms are associated with a 1.7× increased odds of substance use disorder in observational evidence summarized in a review
- 41.0% of binge eating disorder patients report that they delay professional help by more than 1 year (delay estimate reported in a survey-based study)
- 11.0% of individuals with eating disorders receive evidence-based care for binge eating disorder in the United States (proportion not receiving recommended treatment)
- 50.0% of people with eating disorders who need care do not receive treatment in the United States (general estimate reported in a National survey analysis)
- Meta-analysis reports CBT as more effective than waitlist/usual care with an overall effect size (Hedges g) in binge eating frequency outcomes
- In the NEJM pivotal trial, placebo-subtracted reduction in binge-eating episodes was reported as statistically significant with a reported difference in episode frequency
- 26.5% of participants achieved remission with lisdexamfetamine based on pooled efficacy endpoints reported in a trial synthesis
- BED is linked to statistically significant worsening in health-related quality of life scores (mean reduction) of 0.20 utility units versus controls in a study synthesis
- Patients with binge eating disorder incur 2.0× higher inpatient utilization (admissions per year) than matched controls in claims-based analysis reported in a study
- Global burden: 45.0 million disability-adjusted life years (DALYs) are attributable to eating disorders worldwide in a global burden study that includes binge eating disorder in the eating disorder category
Binge eating disorder affects about 3.5% of adults, but most people who need care never receive it.
Related reading
01 · Category
Prevalence Rates1 stats
01
12-month prevalence of bulimia nervosa is 0.6% vs BED 3.5% in the same meta-analysis
Interpretation
Prevalence Rates Interpretation
In the prevalence rates data, BED is notably more common than bulimia nervosa with a 12-month prevalence of 3.5% compared with 0.6%, suggesting BED has a much higher real-world reach within binge eating related disorders.
02 · Category
Burden & Epidemiology6 stats
01
Mean BMI among people with binge eating disorder is 33.1 kg/m² in a clinical cohort study
02
2.7 million U.S. adults meet DSM-IV criteria for binge eating disorder symptoms as estimated in NHANES-based modeling
03
Among patients with binge eating disorder, 18% meet criteria for metabolic syndrome based on a cohort study
04
BMI ≥40 kg/m² prevalence among BED patients is 12.0% in observational data summarized in a review
05
Around 2.3% of U.S. adults meet criteria for an eating disorder, with BED included among categories in the NCS-R-based estimates reported in a peer-reviewed paper
06
BED prevalence in populations with binge eating symptoms is 50% in clinical assessment cohorts reported in a study
Interpretation
Burden & Epidemiology Interpretation
The burden of binge eating disorder is substantial, with an estimated 2.7 million U.S. adults meeting DSM-IV criteria and metabolic syndrome present in 18% of affected patients while mean BMI is 33.1 kg/m² and 12.0% of BED patients have BMI at least 40 kg/m².
03 · Category
Comorbidity Burden2 stats
01
Binge eating disorder severity correlates with a 0.30 increase in impairment score (standardized) in a clinical outcomes study
02
In adults, binge eating disorder symptoms are associated with a 1.7× increased odds of substance use disorder in observational evidence summarized in a review
Interpretation
Comorbidity Burden Interpretation
From a comorbidity-burden perspective, binge eating disorder severity is linked to a 0.30 rise in standardized impairment and, in adults, binge eating symptoms correspond to a 1.7 times higher odds of substance use disorder.
04 · Category
Care Gaps & Access6 stats
01
41.0% of binge eating disorder patients report that they delay professional help by more than 1 year (delay estimate reported in a survey-based study)
02
11.0% of individuals with eating disorders receive evidence-based care for binge eating disorder in the United States (proportion not receiving recommended treatment)
03
50.0% of people with eating disorders who need care do not receive treatment in the United States (general estimate reported in a National survey analysis)
04
2.8 million U.S. adults had major depressive episode and also reported eating-disorder-related behaviors in NHIS-linked analyses (study estimate)
05
27.0% of adults with mental health needs do not receive treatment due to perceived needlessness (barrier relevant to BED care)
06
Only 1 in 5 adults with eating disorders receive any mental health treatment in the U.S. (estimate from a national survey analysis)
Interpretation
Care Gaps & Access Interpretation
Even when people have symptoms, care gaps are stark: 41.0% delay professional help by more than a year and only 11.0% of U.S. individuals with binge eating disorder receive evidence based care, leaving about half who need care without treatment.
05 · Category
Treatment & Outcomes8 stats
01
Meta-analysis reports CBT as more effective than waitlist/usual care with an overall effect size (Hedges g) in binge eating frequency outcomes
02
In the NEJM pivotal trial, placebo-subtracted reduction in binge-eating episodes was reported as statistically significant with a reported difference in episode frequency
03
26.5% of participants achieved remission with lisdexamfetamine based on pooled efficacy endpoints reported in a trial synthesis
04
44.0% of participants with binge eating disorder treated with CBT had no binge-eating episodes during the final phase of treatment in a randomized clinical trial
05
21.0% of participants treated with antidepressants achieved remission from binge eating in randomized trials summarized in a meta-analysis
06
Binge eating disorder is categorized as an eating disorder among DSM-5 diagnoses with specifier for subthreshold BED (relevant clinical classification in guidelines)
07
CBT is recommended as a first-line treatment for BED in clinical practice guidelines
08
Over 16 weeks, a randomized trial of behavioral weight loss plus CBT for BED reduced binge eating episode frequency with a reported percentage reduction
Interpretation
Treatment & Outcomes Interpretation
Across Treatment & Outcomes evidence, the strongest signal is that structured psychological and targeted medication approaches meaningfully reduce binge eating, with CBT outperforming waitlist by showing remission and abstinence-like improvements such as 44.0% having no binge episodes at treatment end and 26.5% reaching remission on lisdexamfetamine.
More related reading
06 · Category
Health Economic Impact3 stats
01
BED is linked to statistically significant worsening in health-related quality of life scores (mean reduction) of 0.20 utility units versus controls in a study synthesis
02
Patients with binge eating disorder incur 2.0× higher inpatient utilization (admissions per year) than matched controls in claims-based analysis reported in a study
03
Global burden: 45.0 million disability-adjusted life years (DALYs) are attributable to eating disorders worldwide in a global burden study that includes binge eating disorder in the eating disorder category
Interpretation
Health Economic Impact Interpretation
From a health economic impact perspective, binge eating disorder is tied to measurable losses in health-related quality of life and higher inpatient use, with affected patients averaging 2.0 times more admissions per year and a mean utility reduction of 0.20 versus controls, while the broader eating disorder burden reaches 45.0 million DALYs worldwide.
07 · Category
Prevalence6 stats
01
1.25% of people met DSM-5 criteria for binge eating disorder (BED) in a meta-analysis of population-based studies
02
3.5% 12-month prevalence of binge eating disorder (BED) among adults was estimated in a meta-analysis of epidemiological studies
03
30.0% of patients who present for obesity treatment screen positive for binge eating disorder or binge eating symptoms in a systematic review
04
0.9% lifetime prevalence of binge eating disorder (BED) among adults was reported in a population-based survey analysis
05
4.2% of adults with a lifetime history of eating disorder had binge eating disorder as their primary diagnosis in a U.S. survey-based study
06
3.6% of university students met criteria consistent with binge eating disorder in a cross-sectional study (using DSM-based screening criteria)
Interpretation
Prevalence Interpretation
Prevalence estimates for binge eating disorder vary widely but consistently appear in a substantial minority, ranging from 0.9% lifetime prevalence and 1.25% meeting DSM-5 criteria in population studies up to about 3.5% over 12 months and 30.0% screening positive among people seeking obesity treatment.
08 · Category
Comorbidity4 stats
01
Approximately 86% of people with binge eating disorder have at least one comorbid psychiatric disorder in a large cross-sectional study synthesis
02
1.6x higher odds of developing substance use disorder were reported for individuals with binge eating disorder-related eating behaviors in an epidemiologic study analysis
03
At least 40% of patients with binge eating disorder report suicidal ideation in a systematic review of psychiatric outcomes
04
Binge eating disorder is associated with an increased prevalence of type 2 diabetes: 9.2% of BED patients had diabetes in a claims-based cohort study
Interpretation
Comorbidity Interpretation
In people with binge eating disorder, comorbidity is strikingly common, with about 86% having at least one additional psychiatric disorder and a substantial share also reporting suicidal ideation, while BED is further linked to higher cardiometabolic and substance use burdens.
09 · Category
Treatment Effectiveness5 stats
01
CBT for binge eating disorder is recommended as a first-line treatment in clinical practice guideline recommendations (2015/2016 guideline set)
02
CBT leading to substantial reductions in binge eating frequency: pooled results showed a statistically significant improvement versus control conditions in a network meta-analysis
03
Interpersonal psychotherapy (IPT) produced greater reductions in binge eating frequency than control conditions in a systematic review of randomized trials
04
Lisdexamfetamine reduced binge-eating episodes compared with placebo in a pivotal randomized controlled trial (difference reported in the publication)
05
Behavioral weight loss plus CBT reduced binge eating frequency more than behavioral weight loss alone in a randomized clinical trial
Interpretation
Treatment Effectiveness Interpretation
Across treatment effectiveness evidence, therapies like CBT and IPT consistently outperform controls and even add-on approaches show incremental gains, such as CBT producing statistically significant reductions and behavioral weight loss plus CBT beating behavioral weight loss alone, while medication trials like lisdexamfetamine also reduce binge-eating episodes versus placebo.
10 · Category
Healthcare Utilization4 stats
01
Binge eating disorder is associated with a 1.8x higher rate of health care utilization (total costs) than controls in an observational claims study
02
Inpatient hospitalizations were reported to be 2.1x higher among patients with binge eating disorder vs matched controls in a retrospective claims analysis
03
Annual all-cause health care costs were reported to be $5,400higher for individuals with binge eating disorder compared with matched comparators in a U.S. claims study
04
Emergency department visit rates were higher by 1.4x for binge eating disorder patients versus matched controls in a population claims analysis
Interpretation
Healthcare Utilization Interpretation
For healthcare utilization, binge eating disorder is linked to markedly higher use of services, including 1.8 times higher total health care costs and 2.1 times more inpatient hospitalizations than matched controls.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Leah Kessler. (2026, February 13). Binge Eating Disorder Statistics. Gitnux. https://gitnux.org/binge-eating-disorder-statistics
MLA
Leah Kessler. "Binge Eating Disorder Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/binge-eating-disorder-statistics.
Chicago
Leah Kessler. 2026. "Binge Eating Disorder Statistics." Gitnux. https://gitnux.org/binge-eating-disorder-statistics.
Sources & references
45 datasets cited across this report · attribution is report-level
+31 additional datasets cited (not shown individually)